Publications

We publish RMOC recommendations and resources, together with a host of other material for the benefit of our users.

Summary The 2020 version of the retention of pharmacy records document is now available. Purpose This document, based on one first generated at the request…
New Medicines Newsletter is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes and new medicines…
A powerpoint slide deck summarising SPS outputs and resources to support NHS teams. It should be distributed by Chief Pharmacists and others to their teams.
Standard Operating Procedure for preparation of AstraZeneca COVID-19 Vaccine in PCN designated sites and end user locations prior to immediate administration.
Outlines the use of pharmacy stock management systems in capturing data for the COVID-19 national vaccination programme.
SOP for transporting the AstraZeneca COVID-19 Vaccine from PCN designated sites to end user locations, patients’ homes and within the PCN Grouping.
Standard Operating Procedure for preparing Pfizer-BioNTech COVID-19 Vaccine syringes for administration at end user locations in primary care.
Standard Operating Procedure for preparation of the Pfizer-BioNTech COVID-19 Vaccine in PCN designated sites prior to immediate administration.
This page outlines key areas where pharmaceutical expertise should be focused to enable the successful national vaccination programmes.
Must read guidance for Chief Pharmacists and others in Trusts on the AstraZeneca COVID-19 vaccine.
This Advisory Statement applies to the London region only. RMOC London recommends that the Pan-London Symptom Control Medicines Authorisation and Administration (MAAR) Chart, developed by…
A draft toolkit has been produced on Best value biologic – insulin glargine, on behalf of the RMOC system. Insulin glargine is the first medicine managed…
The Regional Medicines Optimisation Committee system for England has been developed to address Medicine Optimisation issues which have current impact on practice and where a…
Advice was requested from the Regional Medicines Optimisation Committee (RMOC) regarding the most appropriate and practical approach for the ophthalmology monitoring of patients who are…
Draft guidance has been produced on Buprenorphine long-acting injection: considerations for opioid substitution treatment use in community settings and secure environments in England, on behalf…
The Regional Medicines Optimisation Committee (RMOC, South) has produced an updated advisory statement on the sequential use of biologic medicines which can be accessed below.
RMOC North is leading the work on developing an approach to shared care on behalf of the RMOC system, and is seeking comments on the…
The Regional Medicines Optimisation Committee (RMOC, South) has produced standard principles for medicines prior approval forms which can be accessed below. The document provides advice…
New Medicines Newsletter is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes and new medicines…
New Medicines Newsletter is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes and new medicines…
New Medicines Newsletter is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes and new medicines…
New Medicines Newsletter is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes and new medicines…
New Medicines Newsletter is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes and new medicines…
The July 2020 NHMC Newsletter contains a brief review of the homecare response to the COVID 19 pandemic including  a spotlight on one of the…
For Action: • Dictionary of Medicines and Devices (dm+d) For Information: • Call for Evidence – Update • Model Hospital Update • New guidance and…
Summary The 2020 version of the retention of pharmacy records document is now available. Purpose This document, based on one first generated at the request…
A powerpoint slide deck summarising SPS outputs and resources to support NHS teams. It should be distributed by Chief Pharmacists and others to their teams.
Since this edition of NICE Bites was published, the MHRA has issued restrictions and precautions on the use of fluoroquinolone antibiotics because of rare reports…
This edition of NICE Bites reflects current NICE guidance (as at November 2020). Please go to NICE to check for any recent updates to this…
This edition of NICE Bites reflects current NICE guidance (as at November 2020). Please go to NICE to check for any recent updates to this…
This edition of NICE Bites reflects current NICE guidance (as at November 2020). Please go to NICE to check for any recent updates to this…
This edition of NICE Bites reflects current NICE guidance (as at November 2020). Please go to NICE to check for any recent updates to this…
Since this edition of NICE Bites was published, NICE has updated its guideline to indicate that an ECG is not needed before starting stimulants, atomoxetine…
Several NHS organisations have kindly shared their PGD Audit Tools and standards for consideration and adaptation by other Trusts.  The tools can be found below.
Pharmacy Quality Scheme One of the main aims of the Pharmacy Quality Scheme (PQS) is to help reduce harm from medication. As part of the…
Patient complexity and throughput in acute care have increased over recent years; and pharmacy resources have often remained static or reduced. Targeting resources and skills…
The Medicines Use & Safety team undertook a national baseline audit of the implementation of the RPS Professional Standards for optimising medicines in secure environments…
There is nothing in legislation that prevents the use of PGDs in clinical trials, studies or pilots if the medicine has a product licence and…
UKMi Quality and Risk Management Group   The UKMi user survey is a validated tool, designed to obtain enquirers’ opinions of the service they receive when…
UKMi Quality and Risk Management Group   Good Practice guidance and tools are available for conducting internal and external peer review of Medicines Information services.…
UKMi Quality and Risk Management Group   The revised Audit Toolkit for medicines information services is the culmination of much work and lengthy deliberation.  It replaces several…